https://www.openbell.ai/ 2026-10-15T16:30:57.229Z hourly 1.0 https://www.openbell.ai/support 2026-10-15T16:30:57.229Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-15T16:30:57.229Z monthly 0.5 https://www.openbell.ai/terms 2026-10-15T16:30:57.229Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-15T16:30:57.229Z hourly 0.8 https://www.openbell.ai/news/DVN:1792081782635 2026-10-15T16:29:42.635Z daily 0.9 https://cdn.brandfetch.io/DVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Devon Energy, Raises Price Target to $65 Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on Devon Energy (NYSE: DVN) and raised the price target from $63 to $65. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/BTCUSD:1792081684880 2026-10-15T16:28:04.880Z daily 0.9 https://cdn.brandfetch.io/BTCUSD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bitcoin Bounces Above $82,000 as XRP, Solana Flash Buy Signals Bitcoin has rebounded to $82,000 after previously dipping below $80,000, with significant liquidation clusters identified just below current levels and above $85,000. Analysts have noted buy signals for four major altcoins, including XRP and Solana, with targets of $1.40 and $111 respectively. Bitcoin's immediate resistance is at $84,000, while support is at $78,000 if selling resumes below $79,711. https://www.openbell.ai/news/COP:1792081626871 2026-10-15T16:27:06.871Z daily 0.9 https://cdn.brandfetch.io/COP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on ConocoPhillips, Raises Price Target to $159 Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on ConocoPhillips (NYSE: COP) and raised the price target from $151 to $159. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/INTU:1792081347296 2026-10-15T16:22:27.296Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/New-York-City--New-York---October-7-2025.jpg?width=250&height=187 Intuit Bets on AI-Powered Revenue Automation with Sequence Acquisition Intuit Inc. (NASDAQ: INTU) announced its acquisition of Sequence, an AI-native revenue management platform, which has resulted in a more than 6% increase in its stock price, reaching $329.20. The acquisition aims to enhance Intuit's revenue management offerings for mid-market businesses and expand its capabilities in sectors such as B2B software and healthcare. Financial terms of the deal were not disclosed, but Intuit reiterated its fiscal 2027 revenue guidance of $23.279 billion to $23.512 billion, reflecting a growth of 9% to 10%. https://www.openbell.ai/news/SOXS:1792081332326 2026-10-15T16:22:12.326Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Semiconductor-Or-Microchip-Concepts-tech.jpg?width=250&height=187 AI Financing Fears Hammer Chip Stocks: These 2 ETFs Are Cashing In on the Sell-Off The Direxion Daily Semiconductor Bear 3X Shares ETF (SOXS) and the Direxion Daily Semiconductors Top 5 Bear 2X ETF (TSXD) have benefited from Wall Street's concerns over AI financing, with SOXS rising 13.63% on Wednesday and an additional 12% on Thursday, while TSXD gained about 7% on Thursday. The Philadelphia Semiconductor Index fell 3%, leading to a total market value loss of approximately $1.64 trillion over six sessions. SOXS has crossed above its 50-day moving average, indicating potential further gains if it surpasses the resistance level around $47.19. https://www.openbell.ai/news/CHRD:1792081015349 2026-10-15T16:16:55.349Z daily 0.9 https://cdn.brandfetch.io/CHRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Chord Energy, Raises Price Target to $178 Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on Chord Energy (NASDAQ: CHRD) and increased the price target from $169 to $178. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/BNY:1792080914357 2026-10-15T16:15:14.357Z daily 0.9 https://cdn.brandfetch.io/BNY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bank of New York Mellon Sees FY 2026 Revenue Growth Near Midpoint of 12%-13% Guidance Range, Excluding Notable Items Bank of New York Mellon (NYSE: BNY) anticipates its full-year 2026 total revenue growth, excluding notable items, to be approximately at the midpoint of its guidance range of 12% to 13%. This projection indicates a stable outlook for the company's financial performance in the coming years. https://www.openbell.ai/news/CIFR:1792080866438 2026-10-15T16:14:26.438Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Cipher-Mining--Inc.jpg?width=250&height=187 Cipher Digital Stock Drops as AI Buildout Debt Concerns Persist Cipher Digital Inc (NASDAQ: CIFR) shares fell 5.94% to $9.35, marking a new 52-week low, as concerns over rising debt in the AI cloud sector persist amid hot inflation data. The Bureau of Labor Statistics reported a 1.3% increase in U.S. producer prices for September, significantly above the 0.5% forecast, raising fears of additional Federal Reserve rate hikes. These economic pressures are tightening high-yield credit markets, potentially impacting capital-intensive projects in the AI cloud industry. https://www.openbell.ai/news/CVX:1792080767983 2026-10-15T16:12:47.983Z daily 0.9 https://cdn.brandfetch.io/CVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Chevron, Raises Price Target to $226 Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on Chevron (NYSE: CVX) and increased the price target from $218 to $226. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/BLK:1792080415454 2026-10-15T16:06:55.454Z daily 0.9 https://cdn.brandfetch.io/BLK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on BlackRock, Raises Price Target to $1531 Morgan Stanley analyst Mike Cyprys has maintained an Overweight rating on BlackRock (NYSE: BLK) and increased the price target from $1468 to $1531. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/SNY:1792080357376 2026-10-15T16:05:57.376Z daily 0.9 https://cdn.brandfetch.io/SNY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sanofi Inks Letter Of Intent With pan-Canadian Pharmaceutical Alliance For Dupixent For Four Additional Indications Sanofi has signed a Letter of Intent with the pan-Canadian Pharmaceutical Alliance for its drug Dupixent, expanding its indications to include atopic dermatitis in pediatric patients, prurigo nodularis, severe chronic rhinosinusitis with nasal polyposis, and chronic obstructive pulmonary disease. The company aims to collaborate with public payers to enhance access for eligible patients. https://www.openbell.ai/news/NBIS:1792080240120 2026-10-15T16:04:00.120Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Nebius-Group.jpg?width=250&height=187 Nebius Group Stock Is Falling Thursday: What's Going On? Nebius Group N.V. (NASDAQ: NBIS) saw its stock decline by 5.65% to $175.50 amid selling pressure on artificial intelligence infrastructure stocks due to rising borrowing costs and concerns over capital spending for AI expansion. The stock is currently 22.4% below its 20-day simple moving average (SMA) of $225.92. Despite the recent downturn, Wall Street maintains a consensus Buy rating with an average price forecast of $272.62 from 24 analysts, with forecasts ranging from $84 to $410. https://www.openbell.ai/news/CRM:1792080189148 2026-10-15T16:03:09.148Z daily 0.9 https://cdn.brandfetch.io/CRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of enterprise software companies are trading higher amid an investor rotation from highly leveraged AI-exposed names into the legacy tech services sector. Fears of persistently high inflation and interest rates may increase the appeal of the industry's proven business models. openbell Financial News https://www.openbell.ai/news/NBIS:1792080139530 2026-10-15T16:02:19.530Z daily 0.9 https://cdn.brandfetch.io/NBIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nebius Group Stock Is Falling Thursday: What's Going On? Nebius Group N.V. (NASDAQ: NBIS) saw its stock decline by 5.65% to $175.50 amid selling pressure on artificial intelligence infrastructure stocks due to rising concerns over the capital needed for AI expansion. The technology sector dropped 1.4%, while the Nasdaq fell 0.63%. Analysts maintain a consensus Buy rating with an average price target of $272.62, despite the stock trading 22.4% below its 20-day simple moving average. Investors are cautious as higher borrowing costs could impact future profitability for capital-intensive AI companies. https://www.openbell.ai/news/SJM:1792080132788 2026-10-15T16:02:12.788Z daily 0.9 https://cdn.brandfetch.io/SJM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bernstein Maintains Outperform on JM Smucker, Raises Price Target to $160 Bernstein analyst Alexia Howard has maintained an 'Outperform' rating on JM Smucker (NYSE: SJM) and raised the price target from $157 to $160. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/USO:1792080106442 2026-10-15T16:01:46.442Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud EIA Weekly Distillates Stocks 2.527M Barrel Draw Vs 1.600M Barrel Draw Est. openbell Financial News https://www.openbell.ai/news/DOGEUSD:1792080095977 2026-10-15T16:01:35.977Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Dogecoin-Golden-Cryptocurrency-And-Blue-.jpg?width=250&height=187 Dogecoin Flashes Buy Signal Near $0.08 Support: Is a Rebound Ahead? Dogecoin (DOGE) is currently testing critical support near $0.08, with analysts noting bullish technical signals that could indicate a potential rebound towards $0.087 and resistance at $0.094. The daily TD Sequential indicator has flashed a buy signal, suggesting that selling pressure may be weakening. Additionally, Dogecoin is launching the DogeOS public testnet to expand its utility, which may further support its price. Analysts have identified key resistance levels, with a major breakout target at $0.1186 and long-term targets reaching as high as $2. https://www.openbell.ai/news/USO:1792080062909 2026-10-15T16:01:02.909Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Gasoline Inventories 3.518M Barrel Build Vs 0.500M Barrel Draw Est. openbell Financial News https://www.openbell.ai/news/USO:1792080027024 2026-10-15T16:00:27.024Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Crude Oil Inventories 8.577M Barrel Draw Vs 0.200M Barrel Build Est. openbell Financial News https://www.openbell.ai/news/PFE:1792080023452 2026-10-15T16:00:23.452Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Logo-Pfizer-Inc--Is-An-American-Multinat.jpg?width=250&height=187 Pfizer Stock Hits 52-Week High: What's Going On? Pfizer Inc (NYSE: PFE) shares reached a new 52-week high of $29.88, surpassing the previous peak of $29.21, with a year-over-year increase of 21.8%. This surge follows the FDA's recent approval of the Tukysa regimen for HER2-positive breast cancer, which showed a significant improvement in patient outcomes during clinical trials. The broader pharmaceutical sector is also experiencing gains, with notable increases in stocks like Eli Lilly and Zoetis. At the time of publication, Pfizer shares were up 1.40% at $29.63. https://www.openbell.ai/news/AR:1792079782010 2026-10-15T15:56:22.010Z daily 0.9 https://cdn.brandfetch.io/AR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Overweight on Antero Resources, Raises Price Target to $51 Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on Antero Resources (NYSE: AR) and raised the price target from $49 to $51. This adjustment reflects the firm's positive outlook on the company's performance. https://www.openbell.ai/news/KMB:1792079693201 2026-10-15T15:54:53.201Z daily 0.9 https://cdn.brandfetch.io/KMB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Huggies Maker Kimberly-Clark Sticks To 2026 Profit Outlook Kimberly-Clark Corporation reported preliminary third-quarter net sales of $4.134 billion, a decline of 0.4% year-over-year, while adjusted earnings per share from continuing operations rose 17% to $1.70. The company reaffirmed its full-year 2026 outlook, expecting adjusted operating profit to grow at a mid-single-digit rate and high-single-digit growth in adjusted earnings per share from continuing operations. Despite ongoing pressure on organic sales, Kimberly-Clark's stock rose 4.69% to $104.07 following the announcement. https://www.openbell.ai/news/KMB:1792079581808 2026-10-15T15:53:01.808Z daily 0.9 https://cdn.brandfetch.io/KMB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Huggies Maker Kimberly-Clark Sticks To 2026 Profit Outlook Kimberly-Clark Corporation (NASDAQ: KMB) reported preliminary third-quarter net sales of $4.134 billion, a decline of 0.4% year-over-year, while adjusted earnings per share from continuing operations increased by 17% to $1.70. The company reaffirmed its full-year 2026 outlook, expecting mid-single-digit growth in adjusted operating profit and high-single-digit growth in adjusted earnings per share from continuing operations, despite pressures on organic sales. Kimberly-Clark's stock rose 4.69% to $104.07 following the announcement. https://www.openbell.ai/news/LLY:1792079482945 2026-10-15T15:51:22.945Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Eli-Lilly.jpg?width=250&height=187 Eli Lilly Says New Drug Drives Comprehensive Disease Control in Ulcerative Colitis Patients Eli Lilly and Co. announced new data showing that its drug Omvoh (mirikizumab) significantly aids patients with moderately to severely active ulcerative colitis (UC) and Crohn's disease in achieving comprehensive disease control after one year. In the LUCENT studies, 27.7% of patients on Omvoh reached this endpoint compared to 14% on placebo, while in the VIVID-1 analysis, 20.4% of Crohn's disease patients achieved corticosteroid-free deep remission with Omvoh versus just 2% on placebo. Following the announcement, Eli Lilly's shares rose 4.81% to $1,268.10. https://www.openbell.ai/news/LNC:1792079381198 2026-10-15T15:49:41.198Z daily 0.9 https://cdn.brandfetch.io/LNC/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Underweight on Lincoln National, Lowers Price Target to $47 JP Morgan analyst Pablo Singzon has maintained an Underweight rating on Lincoln National (NYSE: LNC) and has lowered the price target from $49 to $47. https://www.openbell.ai/news/TXRH:1792079199966 2026-10-15T15:46:39.966Z daily 0.9 https://cdn.brandfetch.io/TXRH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stephens & Co. Upgrades Texas Roadhouse to Overweight, Maintains Price Target to $205 Stephens & Co. analyst Jim Salera has upgraded Texas Roadhouse (NASDAQ: TXRH) from Equal-Weight to Overweight. The firm has maintained its price target for the stock at $205. https://www.openbell.ai/news/BAC:1792079103320 2026-10-15T15:45:03.320Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: Bank of America's Bond Losses Swell to $109 Billion Bank of America reported $109 billion in unrealized bond losses for Q3, up from $85 billion in June, alongside a 17% decline in fixed income trading revenue. The bank also faced over $1.21 billion in penalties from U.S. regulators for anti-money laundering violations, marking the third-largest penalty in Treasury history. Additionally, Bank of America missed earnings estimates with quarterly earnings of $1.08 per share and revenue of $29.96 billion, both falling short of analyst expectations. Analysts have adjusted their ratings, with RBC Capital lowering the price target from $65 to $60, while Baird upgraded the bank from Neutral to Outperform with a price target of $62. https://www.openbell.ai/news/BAC:1792078997391 2026-10-15T15:43:17.391Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Massachusetts--Usa---26-July-2024--Bank-.jpg?width=250&height=187 This Bank of America Analyst Cuts Estimates After Q3 Results Bank of America Corporation (NYSE: BAC) reported third-quarter earnings of 91 cents per share, missing the consensus estimate of $1.10 per share. Analyst Scott Siefers from Piper Sandler reiterated a Hold rating and lowered the price target from $60 to $56, while also reducing earnings estimates for 2026 and 2027. Despite the earnings miss, Siefers noted a constructive outlook with improving net interest margin and guidance for net interest income growth of over 8% into 2027. Bank of America's shares declined 0.29% to $51.26 following the report. https://www.openbell.ai/news/EDUC:1792078975205 2026-10-15T15:42:55.205Z daily 0.9 https://cdn.brandfetch.io/EDUC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Educational Development shares are trading lower after the company reported a year-over-year decrease in its Q2 financial results. openbell Financial News https://www.openbell.ai/news/OPK:1792078894633 2026-10-15T15:41:34.633Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Business-Mergers-And-Acquisitions-Concep.jpg?width=250&height=187 OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal Labcorp Holdings Inc. has agreed to acquire select assets of BioReference Health from OPKO Health Inc. in a deal valued at up to $872 million, which includes $722 million in cash at closing and potential additional payments tied to revenue from the 4Kscore Test. OPKO Health shares rose nearly 8% following the announcement, reflecting a strategic shift towards its biopharmaceutical business. The acquisition is expected to generate approximately $250 million in revenue for Labcorp in the first year after closing, pending regulatory approvals. https://www.openbell.ai/news/AMOD:1792078759877 2026-10-15T15:39:19.877Z daily 0.9 https://cdn.brandfetch.io/AMOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alpha Modus shares are trading higher after the company announced that its subsidiary, Alpha Modus Corp., entered into an agreement with Autry Greer & Sons to test and evaluate its proprietary ARIA AI platform within Greer’s grocery retail operations. openbell Financial News https://www.openbell.ai/news/XPEV:1792078735957 2026-10-15T15:38:55.957Z daily 0.9 https://cdn.brandfetch.io/XPEV/w/400/h/400?c=1idopYfmtR7ZKg8QMud XPENG To Offer Google Play Within Its Cars XPENG (NYSE: XPEV, HKEX: 9868) has announced a native integration with Google Play, enhancing its strategic collaboration with Google. This integration will allow XPENG vehicles to offer a range of automotive-optimized apps, providing users with a seamless experience without needing their phones. The feature is set to go live in early 2027, giving XPENG users access to hundreds of apps across various categories, including music, navigation, and lifestyle services. https://www.openbell.ai/news/FRGT:1792078573510 2026-10-15T15:36:13.510Z daily 0.9 https://cdn.brandfetch.io/FRGT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Freight Technologies shares are trading lower after the company announced a 1-for-10 reverse stock split. openbell Financial News https://www.openbell.ai/news/HUMA:1792078518471 2026-10-15T15:35:18.471Z daily 0.9 https://cdn.brandfetch.io/HUMA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Humacyte shares are trading higher after the company reported a 44% increase in the number of hospitals ordering Symvess in Q3 2026. openbell Financial News https://www.openbell.ai/news/NVDA:1792078476027 2026-10-15T15:34:36.027Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Nvidia CEO Huang Says CoreWeave Improving, No Backstop Needed' - Bloomberg Nvidia CEO Jensen Huang announced that CoreWeave, a cloud computing company, is showing improvement and does not require a financial backstop. This statement reflects confidence in CoreWeave's operational progress. The news may positively influence Nvidia's stock performance as it highlights the company's strategic partnerships and growth in the cloud computing sector. https://www.openbell.ai/news/SNES:1792078319806 2026-10-15T15:31:59.806Z daily 0.9 https://cdn.brandfetch.io/SNES/w/400/h/400?c=1idopYfmtR7ZKg8QMud SenesTech shares are trading higher after the company reported preliminary Q3 2026 revenue of approximately $1.1 million, representing approximately 55% growth compared with the Q3 revenue of 2025. openbell Financial News https://www.openbell.ai/news/MU:1792077992949 2026-10-15T15:26:32.949Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Silicon-Wafer-With-Microchips-Used-In-El.jpg?width=250&height=187 Chip Meltdown Hits Micron, SanDisk and SK Hynix: $1 Trillion Vanishes From Memory Makers The memory chip sector has experienced a significant downturn, with six major companies, including SK Hynix, Samsung, Micron, and SanDisk, losing over $1 trillion in market value since October 2. SK Hynix's shares fell 11.1%, resulting in a loss of approximately $352.7 billion, while Micron's stock declined 4.4%, leading to a loss of $227.1 billion. The broader market impact includes a 7.6% drop in the Kospi index and the iShares Semiconductor ETF (SOXX) down 3.3%, marking its eighth consecutive loss. https://www.openbell.ai/news/AMRO:1792077900539 2026-10-15T15:25:00.539Z daily 0.9 https://cdn.brandfetch.io/AMRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO security released for quotation openbell Financial News https://www.openbell.ai/news/DG:1792077685962 2026-10-15T15:21:25.962Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Central-City-Illinois---May-2018-Dollar-.jpg?width=250&height=187 Stock of the Day: Is Dollar General Breaking Out? Dollar General Corporation (NYSE: DG) shares are experiencing an upward trend and may be breaking through a resistance level of $132.50, which previously halted a rally in early September. This potential breakout could indicate a bullish dynamic, suggesting that buyers may continue to push the stock higher if they can maintain momentum above this resistance. The stock has been designated as the 'Stock of the Day' due to these developments. https://www.openbell.ai/news/RGA:1792077673182 2026-10-15T15:21:13.182Z daily 0.9 https://cdn.brandfetch.io/RGA/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Reinsurance Group, Raises Price Target to $297 JP Morgan analyst Pablo Singzon has maintained an Overweight rating on Reinsurance Group (NYSE:RGA) and raised the price target from $293 to $297. This adjustment reflects a positive outlook for the company in the reinsurance sector. https://www.openbell.ai/news/CRM:1792077652659 2026-10-15T15:20:52.659Z daily 0.9 https://cdn.brandfetch.io/CRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Salesforce Inks 15-Year, £2B Agreement With HM Revenue & Customs To Upgrade Its Services For U.K. Tax Payers Salesforce has signed a 15-year agreement worth £2 billion with HM Revenue & Customs (HMRC) to modernize tax services for U.K. citizens and businesses. This partnership aims to enhance the efficiency and effectiveness of tax services provided by HMRC. The deal is part of Salesforce's strategy to expand its presence in the public sector. https://www.openbell.ai/news/MET:1792077584736 2026-10-15T15:19:44.736Z daily 0.9 https://cdn.brandfetch.io/MET/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on MetLife, Raises Price Target to $110 JP Morgan analyst Pablo Singzon has maintained an Overweight rating on MetLife (NYSE: MET) and raised the price target from $108 to $110. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/GL:1792077396202 2026-10-15T15:16:36.202Z daily 0.9 https://cdn.brandfetch.io/GL/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Globe Life, Raises Price Target to $195 JP Morgan analyst Pablo Singzon has maintained an Overweight rating on Globe Life (NYSE: GL) and raised the price target from $193 to $195. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/BLK:1792077309267 2026-10-15T15:15:09.267Z daily 0.9 https://cdn.brandfetch.io/BLK/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on BlackRock, Raises Price Target to $1449 JP Morgan analyst Michael Cho has maintained an Overweight rating on BlackRock (NYSE: BLK) and increased the price target from $1435 to $1449. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/NVDA:1792077150265 2026-10-15T15:12:30.265Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud NVIDIA Unveils 120B-Parameter Nemotron 3.5 Super VL For Enterprise AI Agents NVIDIA has introduced the Nemotron 3.5 Super VL, a new AI model featuring 120 billion parameters designed for enterprise AI agents. This model enhances multimodal reasoning capabilities, allowing for more specialized applications in various industries. The launch is part of NVIDIA's ongoing efforts to strengthen its position in the AI market, particularly in enterprise solutions. https://www.openbell.ai/news/GOOG:1792077114610 2026-10-15T15:11:54.610Z daily 0.9 https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Alphabet, Raises Price Target to $425 JP Morgan analyst Doug Anmuth has maintained an Overweight rating on Alphabet (NASDAQ: GOOG) and raised the price target from $420 to $425. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/AMCX:1792076945519 2026-10-15T15:09:05.519Z daily 0.9 https://cdn.brandfetch.io/AMCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Maintains Underweight on AMC Global Media, Lowers Price Target to $9 Morgan Stanley analyst Thomas Yeh has maintained an Underweight rating on AMC Global Media (NASDAQ: AMCX) and has reduced the price target from $10 to $9. This adjustment reflects the firm's cautious outlook on the company's performance. https://www.openbell.ai/news/WMG:1792076802961 2026-10-15T15:06:42.961Z daily 0.9 https://cdn.brandfetch.io/WMG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Warner Music Group shares are trading higher after StoneX initiated its coverage on the stock with a Buy rating and announced a price target of $41. openbell Financial News https://www.openbell.ai/news/VSTM:1792076516965 2026-10-15T15:01:56.965Z daily 0.9 https://cdn.brandfetch.io/VSTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Verastem, Raises Price Target to $19 RBC Capital analyst Leonid Timashev has maintained an 'Outperform' rating on Verastem (NASDAQ: VSTM) and raised the price target from $14 to $19. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/CAT:1792076512586 2026-10-15T15:01:52.586Z daily 0.9 https://cdn.brandfetch.io/CAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Caterpillar Investing $10M In Its North Carolina Operations Caterpillar Inc. (NYSE: CAT) is investing up to $10 million in its North Carolina operations as part of its five-year, $100 million Building the Future Workforce Initiative. This funding is aimed at preparing current and future workers for jobs in modern manufacturing and industry technician roles.